back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-11-09 Tx date 2018-11-08 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,438,200
+340,000 vol $4.23 each |
1,022,332 | |
| Filed 2017-11-13 Tx date 2017-11-09 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,222,000
+100,000 vol $12.22 each |
682,332 | |
| Filed 2017-08-21 Tx date 2017-08-17 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,760
+2,100 vol $5.60 each |
12,800 | |
| Filed 2017-08-21 Tx date 2017-08-21 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,210
+2,200 vol $5.55 each |
15,000 | |
| Filed 2017-08-18 Tx date 2017-08-17 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,955
+700 vol $5.65 each |
10,700 | |
| Filed 2017-08-18 Tx date 2017-08-16 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,464
+4,000 vol $5.62 each |
10,000 | |
| Filed 2016-12-23 Tx date 2016-12-23 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,643
+3,000 vol $7.88 each |
6,000 | |
| Filed 2016-12-13 Tx date 2016-12-12 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,228
+3,000 vol $8.08 each |
3,000 | |
| Filed 2016-12-13 Tx date 2011-07-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-10 Tx date 2016-07-18 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-50,010
-1,667 vol $30.00 each |
525,309 | |
| Filed 2016-11-10 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$524,611
+57,023 vol $9.20 each |
582,332 | |
| Filed 2016-09-01 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+134,848 vol |
338,788 | |
| Filed 2016-09-01 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+134,848 vol |
||
| Filed 2016-05-30 Tx date 2016-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+94,094 vol |
526,976 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+94,094 vol |
432,882 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,045,444 vol |
203,940 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+159,768 vol |
4,249,384 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,793,025 vol |
4,089,616 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+42,505 vol |
8,882,641 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,275,141 vol |
8,840,136 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-50,000 vol |
10,113,610 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+1,667 vol |
10,115,277 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+134,848 vol |
338,788 |